Real-world Experience of Catheter Ablation for the Treatment of Paroxysmal and Persistent Atrial Fibrillation

Launched by HEART RHYTHM CLINICAL AND RESEARCH SOLUTIONS, LLC · Sep 10, 2019

Keywords

ClinConnect Summary

This clinical trial is looking at how well a treatment called catheter ablation works for people with two types of heart rhythm problems known as Paroxysmal Atrial Fibrillation (PAF) and Persistent Atrial Fibrillation (PsAF). Catheter ablation is a procedure that uses heat to destroy small areas of heart tissue that may be causing these irregular heartbeats. The goal of the study is to gather real-world information on how effective and safe this treatment is for patients, as well as how smoothly the procedure goes.

To participate in this trial, you must be at least 18 years old and have been diagnosed with either symptomatic Paroxysmal or Persistent Atrial Fibrillation, meaning your heart rhythm problems are causing noticeable symptoms. You should be a candidate for the ablation procedure and be willing to attend follow-up evaluations. However, if you have a more severe form of Atrial Fibrillation that has lasted over a year, or if you're currently in another clinical trial, you might not be eligible. Participants can expect to contribute valuable information that could help improve treatment options for others with similar heart conditions.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Symptomatic Paroxysmal (AF episode terminate spontaneously within 7 days) or Persistent (AF sustained beyond 7 days) who, in the opinion of the investigator, are candidates for ablation for AF
• • 18 years of age or older
• • De Novo ablation procedure unless it is a repeat for a patient whose index procedure is also in the registry
• • Able and willing to participate in baseline and follow up evaluations for the full length of the registry
• • Willing and able to provide informed consent, if applicable
• Exclusion Criteria:
• • Enrolled in an investigational drug or device clinical trial, or any trial that dictates the treatment plan
• • Long-standing persistent AF (AF greater than one year's duration)
• • Having a repeat ablation, unless the subject's index ablation procedure is also included in the registry
• • In the opinion of the investigator, any known contraindication to an ablation procedure